Faculty
Oncology Division
Andrea Wang-Gillam, MD, PhD
Associate Professor
Department of Medicine
Oncology Division
Molecular Oncology
Research Interests
- Pancreatic cancer
Contact
- 314-362-5740 (office)
- 314-362-7086 (fax)
- awang-gillam@wustl.edu
- Division of Oncology
Campus Box 8056
Washington University
660 South Euclid Avenue
St. Louis, MO 63110 - 11th Floor Mid Campus Center (office)
Biosketch
| Education | |
|---|---|
| 1990-1993 | BS in Biology and Chemistry, Ouachita Baptist University, Arkadelphia, AR |
| 1995-2001 | MD, PhD, University of Arkansas College of Medicine, Little Rock, AR |
| Post-graduate Training | |
| 2001-2002 | Intern, Internal Medicine, Cleveland Clinic Foundation, Cleveland, OH |
| 2002-2004 | Resident, Internal Medicine, University of Arkansas for Medical Sciences, Little Rock, AR |
| 2004-2007 | Fellow, Hematology/Oncology, University of Arkansas for Medical Sciences, Little Rock, AR |
| Academic Positions | |
| 2007-2015 | Assistant Professor, Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO |
| 2015-present | Associate Professor, Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO |
| 2015-present | Clinical Director, Gastrointestinal Oncology Program, Division of Oncology, Washington University School of Medicine, St. Louis, MO |
| 2017-2020 | Director, Developmental Therapeutics Program, Division of Oncology, Washington University School of Medicine, St. Louis, MO |
| National Committees | |
| 2007–2011 | Committee Member, Medical Oncology Committee, American College of Surgeons Oncology Group |
| 2010-2011 | Junior Investigator, National Cancer Institute Pancreatic Cancer Task Force |
| 2010–2012 | Committee Member, Scientific Program Committee, American Society of Clinical Oncology |
| 2011-present | Committee Member, GI Committee, Alliance for Clinical Trials in Oncology |
| 2017-present | Committee Member, Investigational Drug Steering Committee of NIH |
| 2018-present | Committee Member, Pancreatic Cancer Task Force, Gastrointestinal Cancer Steering Committee of National Cancer Institute |
| University & Hospital Committees | |
| 2007–2010 | Committee Member, Protocol Review and Monitoring Committee, Siteman Cancer Center |
| 2013-present | Siteman Cancer Center Upper GI Focus Group Leader |
| 2014-present | Committee Member, Protocol Review and Monitoring Committee |
| 2017-present | Siteman Cancer Center Drug Developmental Program Focus Group Leader |
| 2017-present | Siteman Cancer Center Senior Leadership Clinical Research Subcommittee |
| Board Certification | |
| 2004 | Internal Medicine |
| 2007, 2017 | Medical Oncology |
| Honors & Awards | |
| 1996-2001 | MD-PhD Scholarship, University of Arkansas for Medical Sciences |
| 2008-2009 | Siteman Cancer Research Development Award |
| 2011-2012 | Siteman Cancer Center Protocol Specific Research Support Award |
| 2015-2018 | Best Doctors in America List |
| Professional Societies & Organizations | |
| 2004-present | Member, American Society of Clinical Oncology |
| 2008-present | Member, American Pancreatic Cancer Association |
| 2013-present | Member, American Association for Cancer Research |
| Scientific Grant Review | |
| 2013, 2015, 2017 | Peer Reviewer, Cancer Research Program for the Department of Defense Congressionally Directed Medical Research Program |
| 2015, 2017, 2018 | Cancer Research UK |
| 2016 | Pennsylvania Department of Health Review |
| 2016 | Florida Department of Health Review |
| 2018 | NIH Study Section |
| 2019-2025 | NIH Developmental Therapeutic Study Section |
